Return on investment of public health interventions: a systematic review
Open accessThe DOI matches its Crossref record; 55 of the 58 references it cites were found in a registry or an index; 7 of the 47 sources its claims cite were checked for support.
Abstract
BACKGROUND: Public sector austerity measures in many high-income countries mean that public health budgets are reducing year on year. To help inform the potential impact of these proposed disinvestments in public health, we set out to determine the return on investment (ROI) from a range of existing public health interventions. METHODS: We conducted systematic searches on all relevant databases (including MEDLINE; EMBASE; CINAHL; AMED; PubMed, Cochrane and Scopus) to identify studies that calculated a ROI or cost-benefit ratio (CBR) for public health interventions in high-income countries. RESULTS: We identified 2957 titles, and included 52 studies. The median ROI for public health interventions was 14.3 to 1, and median CBR was 8.3. The median ROI for all 29 local public health interventions was 4.1 to 1, and median CBR was 10.3. Even larger benefits were reported in 28 studies analysing nationwide public health interventions; the median ROI was 27.2, and median CBR was 17.5. CONCLUSIONS: This systematic review suggests that local and national public health interventions are highly cost-saving. Cuts to public health budgets in high income countries therefore represent a false economy, and are likely to generate billions of pounds of additional costs to health services and the wider economy.
Overview
CoChat Summary
TL;DR
This systematic review of 52 studies found that public health interventions in high-income countries are highly cost-saving, with a median return on investment (ROI) of 14.3:1 and median cost-benefit ratio (CBR) of 8.3. Local interventions had a median ROI of 4.1:1, while national interventions had a median ROI of 27.2:1.
Key findings
- Across 52 included studies, the median ROI for public health interventions was 14.3 and median CBR was 8.3; reported ROIs ranged from −21.27 to 221, and CBRs ranged from 0.66 to 167.
- Local public health interventions (29 studies) had a median ROI of 4.1 and median CBR of 10.3; national public health interventions (28 studies) had a median ROI of 27.2 and median CBR of 17.5.
- By specialism, median ROI was 34.2 for health protection, 46.5 for legislative interventions, 2.2 for health promotion, 5.1 for healthcare public health, and 5.6 for wider determinants; median CBRs were 41.8, 5.8, 14.4, not reported for healthcare public health, and 7.1, respectively.
- Using the conservative CBR of 8.3, the authors estimate that £200 million cuts to public health funding in England imply an opportunity cost of around £1.6 billion, concluding that cuts represent a false economy.
Methods
- Systematic review searching PubMed, MEDLINE, Scopus, CINAHL, Cochrane, PsycInfo and AMED, plus hand-searching and grey literature, for studies of any design reporting ROI or CBR for public health interventions in high-income countries with universal healthcare.
- From 2957 identified titles, 52 studies were included; two reviewers screened and extracted data, with a third adjudicating disagreements, and quality was assessed using the NICE quality appraisal checklist for economic evaluations.
- No formal meta-analysis was conducted because ROI was calculated inconsistently, with differing cost perspectives, time horizons and discount rates ranging from 0% to 10%.
Limitations
- The paper states difficulty defining what constitutes a “public health intervention,” likely publication bias and possible missed studies, no formal meta-analysis due inconsistent ROI calculations, variable generalisability across countries, and considerable variation in economic evaluation quality.
- The paper also states that most studies report only one of ROI or CBR, and that studies reporting ROI tend to have higher estimates; studies at the extreme ROI range tended to be of poorer quality, while CBR-reporting studies tended to be higher quality.
- Evident from the text: some included studies focused on vaccination practices no longer employed in several countries, and many workplace health promotion studies came from the USA, where employer incentives may limit transferability to other health systems.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
5 Valid · 4 Not valid · 23 Not checked · 35 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The median ROI was 2.2 (range 0.712 to 6.213).”
§ Return on investment of public health interventions: a systematic review > Results > ROI of public health programmes stratified by specialism
What the sources say
- Could not verifycites [12] Evans-Lacko, 2013, Economic evaluation of the anti-sigma social marketing campaign in England 2009-2011, Br J Psychiatry sourceExperimental — accuracy not yet measured
The Return on investment section reports scenario-dependent returns for one anti-stigma campaign, not a median ROI across health promotion interventions. Searches for the median of 2.2 and the stated range found no matching passage in our copy. (LLM, conf=0.76)
- Not matchedcites [13] Trust for America's Health. Prevention for a healthier America: investments in disease prevention yield substantial savings, stronger communities. Washington DC: Trust for America, 2008.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The median ROI was 5.6 (range 1.119 to 10.820) with a median CBR of 7.1”
§ Return on investment of public health interventions: a systematic review > Results > ROI of public health programmes stratified by specialism
What the sources say
- Not checked — no full text of the sourcecites [19] source
- Could not verifycites [20] Reynolds, 2011, Age 26 cost-benefit analysis of the child-parent center early education program, Child Dev sourceExperimental — accuracy not yet measured
The Results (Cost-Benefit Estimates; page unavailable) report returns for the Child-Parent Center program’s components, not a median ROI across wider determinants interventions. Searches for the stated median, range, and CBR found no passage in our copy reporting those figures. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The ROIs ranged from –21.27 (influenza vaccination of healthy workers7) to 221 (lead paint control8).”
§ Return on investment of public health interventions: a systematic review > Results
What the sources say
- Not checked — no full text of the sourcecites [7] source
- Supportedcites [8] source
The Discussion (page not provided) reports a return of $17–$221 for each dollar invested in lead hazard control. This confirms the 221 endpoint attributed to Gould; the −21.27 endpoint is attributed to a different citation. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The median ROI was 46.5 (range 3815 to 5515).”
- Also stated in: § Legislative interventions · plain
“with a median ROI of 46.5.”
§ Return on investment of public health interventions: a systematic review > Results > ROI of public health programmes stratified by specialism
What the sources say
- Supportedcites [15] source
Table 2 (Results) reports net savings of $38 per dollar spent for the TV-advertising tax change and $55 per dollar spent for the sugar-sweetened beverage excise tax. For these two tax interventions, the range is $38–$55 and the calculated median is $46.5; the paper does not state the median explicitly. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Legislative interventions · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“Introducing a sugar sweetened beverage tax could save $55 for every single dollar invested15 in the USA.”
§ Return on investment of public health interventions: a systematic review > Discussion > Legislative interventions
What the sources say
- Supportedcites [15] source
The Results state that the sugar-sweetened beverage excise tax would save an estimated $55 for every dollar spent. Table 2 identifies this as a modeled U.S. outcome over 2015–2025, matching the claim's figure and setting. (LLM, conf=0.94)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
42 more claims · 1 with their cited sources checked
Create a free account to see all 67 claims and to verify the 4 references still open.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 14
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Public oral health care is often the first service to suffer as it is considered to be expensive and not essential, resulting in increased unmet oral health care needs.[75][76][77]”
From Ending the neglect of global oral health: time for radical action. (2019) · cites this paper as [75]
Experimental — accuracy not yet measuredIn the citing paper
“Employment is demonstrated to reduce the risk of depression, 443 possibly by providing a greater sense of autonomy, improved socioeconomic status, and avenues for personal development. 444”
From Time for united action on depression: a Lancet–World Psychiatric Association Commission (2022) · cites this paper as [444]
In the citing paper
“Policy interventions at a population level to create environments that improve diet and physical activity are often cost-saving and facilitate people making healthy choices.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [28]
In the citing paper
“where returns on investment tend to be diffuse and unfold slowly over time [77].”
From Translating economic evaluations into financing strategies for implementing evidence-based practices (2021) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Return on investment of public health interventions: a systematic review > Results
“The ROIs ranged from –21.27 (influenza vaccination of healthy workers7) to 221 (lead paint control8).”
§ Return on investment of public health interventions: a systematic review > Results > ROI of public health programmes stratified by specialism
“The ROI median was 34.2, and ranged from −21.37 to 2218”
Citations
Cites
The National Institute for Clinical Excellence
(2001) · Nursing Management · doi:10.7748/nm.8.2.39.s15 · Cited by 3,876
(2005) · Medical Entomology and Zoology · Cited by 1,313
Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S., Devlin, N., Smith, P. C., & Sculpher, M. (2015) · Health Technology Assessment · doi:10.3310/hta19140 · Cited by 853
Gupta, J. K., Daniels, J. P., Middleton, L. J., Pattison, H. M., Prileszky, G., Roberts, T. E., Sanghera, S., Barton, P., Gray, R., Kai, J., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19880 · Cited by 399
Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence
Creese, A., Floyd, K., Alban, A., & Guinness, L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08595-1 · Cited by 394
Age 26 Cost–Benefit Analysis of the Child-Parent Center Early Education Program
Reynolds, A. J., Temple, J. A., White, B. A. B., Ou, S.-R., & Robertson, D. L. (2011) · Child Development · doi:10.1111/j.1467-8624.2010.01563.x · Cited by 341
Gould, E. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800408 · Cited by 319
Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza
Nichol, K. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.5.749 · Cited by 258
Health education for pregnant smokers: its behavioral impact and cost benefit.
Windsor, R. A., Lowe, J. B., Perkins, L. L., Smith-Yoder, D., Artz, L., Crawford, M., Amburgy, K., & Boyd, N. R. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.2.201 · Cited by 250
Drummond, M., Brandt, A., Luce, B., & Rovira, J. (1993) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300003007 · Cited by 230 · cited 1×
“Discount rates 62 Conversely, a 1 year time horizon may offer too short a time frame.”
Background
Cited by
Time for united action on depression: a Lancet–World Psychiatric Association Commission
Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02141-3 · Cited by 1,104
Ending the neglect of global oral health: time for radical action.
Watt, R. G., Daly, B., Allison, P., Macpherson, L. M. D., Venturelli, R., Listl, S., Weyant, R. J., Mathur, M. R., Guarnizo-Herreño, C. C., Celeste, R. K., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31133-x · Cited by 1,029
OECD, & Fund, T. K. (2020) · OECD eBooks · doi:10.1787/47a04a11-en · Cited by 435
Racial Disparities in COVID‐19 Mortality Among Essential Workers in the United States
Rogers, T. N., Rogers, C. R., VanSant‐Webb, E., Gu, L. Y., Yan, B., & Qeadan, F. (2020) · World Medical & Health Policy · doi:10.1002/wmh3.358 · Cited by 309
“Laster Pirtle (2020) and Milam et al. (2020), our study reveals the need for interventions to address social inequality among groups most at risk for unfair or unequal treatment.”
BackgroundTurner, H. C., Archer, R. A., Downey, L. E., Isaranuwatchai, W., Chalkidou, K., Jit, M., & Teerawattananon, Y. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.722927 · Cited by 221
Wuhan novel coronavirus (COVID-19): why global control is challenging?
Lee, A. (2020) · Public Health · doi:10.1016/j.puhe.2020.02.001 · Cited by 236
Tregoning, J. S., Brown, E. S., Cheeseman, H. M., Flight, K. E., Higham, S. L., Lemm, N.-M., Pierce, B. F., Stirling, D. C., Wang, Z., & Pollock, K. M. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13517 · Cited by 224
Powering population health research: Considerations for plausible and actionable effect sizes
Matthay, E. C., Hagan, E., Gottlieb, L. M., Tan, M. L., Vlahov, D., Adler, N., & Glymour, M. M. (2021) · SSM - Population Health · doi:10.1016/j.ssmph.2021.100789 · Cited by 177
Guzman-Castillo, M., Ahmadi‐Abhari, S., Bandosz, P., Capewell, S., Steptoe, A., Singh‐Manoux, A., Mika Kivimaki, B., Shipley, M. J., Brunner, E. J., & O’Flaherty, M. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30091-9 · Cited by 180
Self-citationMcGowan, V. J., Buckner, S., Mead, R., McGill, E., Ronzi, S., Beyer, F. R., & Bambra, C. L. (2021) · BMC Public Health · doi:10.1186/s12889-021-11852-z · Cited by 219
Sojobi, A. O., & Zayed, T. M. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111609 · Cited by 169
COVID-19 and the Social Determinants of Health
Rollston, R. L., & Galea, S. (2020) · American Journal of Health Promotion · doi:10.1177/0890117120930536b · Cited by 158
Enserro, D. M., Vasan, R. S., & Xanthakis, V. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008741 · Cited by 118
Reimagining Public Health in the Aftermath of a Pandemic
Brownson, R. C., Burke, T. A., Colditz, G. A., & Samet, J. M. (2020) · American Journal of Public Health · doi:10.2105/ajph.2020.305861 · Cited by 126
McCluskey, G., Doherty‐Allan, R., McCarron, P., Loftus, A. M., McCarron, L. V., Mulholland, D. A., McVerry, F., & McCarron, M. O. (2018) · European Journal of Neurology · doi:10.1111/ene.13739 · Cited by 129
“As there is increasing evidence that public health interventions demonstrate cost-effective health benefits [37], this work suggests that population-based epidemiological studies of IIH offer an outcome measure from public health interventions especially if targeted at younger people.”
BackgroundAnderson, M., Pitchforth, E., Asaria, M., Brayne, C., Casadei, B., Charlesworth, A., Coulter, A., Franklin, B. D., Donaldson, C., Drummond, M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00232-4 · Cited by 127
Safety-in-numbers: An updated meta-analysis of estimates
Elvik, R., & Goel, R. (2019) · Accident Analysis & Prevention · doi:10.1016/j.aap.2019.05.019 · Cited by 97
An effectiveness hierarchy of preventive interventions: neglected paradigm or self-evident truth?
Capewell, S., & CAPEWELL, A. E. (2017) · Journal of Public Health · doi:10.1093/pubmed/fdx055 · Cited by 102
Self-citationPeters, G.-J., Ruiter, R. A. C., ten Hoor, G. A., Kessels, L. T. E., & Kok, G. (2018) · Health Psychology Review · doi:10.1080/17437199.2018.1454846 · Cited by 94
Stokes, J., Guthrie, B., Mercer, S. W., Rice, N., & Sutton, M. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003514 · Cited by 101
“There is some evidence that, particularly public health, preventative interventions can be highly cost-effective, nevertheless [38-40].”
BackgroundAdverse childhood experiences: A scoping review of measures and methods
Karatekin, C., Mason, S. M., Riegelman, A., Bakker, C., Hunt, S., Gresham, B. L., Corcoran, F., & Barnes, A. J. (2022) · Children and Youth Services Review · doi:10.1016/j.childyouth.2022.106425 · Cited by 109
Ishaq, S. L., Parada, F. J., Wolf, P. G., Bonilla, C. Y., Carney, M. A., Benezra, A., Wissel, E. F., Friedman, M., DeAngelis, K. M., Robinson, J. M., et al. (2021) · mSystems · doi:10.1128/msystems.00471-21 · Cited by 86
São Paulo call to action for the prevention and control of high blood pressure: 2020
Campbell, N. R. C., Schutte, A. E., Varghese, C. V., Ordunez, P., Zhang, X., Khan, T., Sharman, J. E., Whelton, P. K., Parati, G., Weber, M. A., et al. (2019) · The Journal of Clinical Hypertension · doi:10.1111/jch.13741 · Cited by 72
Economic development and health outcomes: Evidence from cardiovascular disease mortality in Europe
Spiteri, J., & BROCKDORFF, P. V. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2019.01.050 · Cited by 74
Kneale, D., Rojas‐García, A., & Thomas, J. (2019) · Health Research Policy and Systems · doi:10.1186/s12961-019-0446-x · Cited by 54
Cook, P. A., Hargreaves, S. C., Burns, E. J., de Vocht, F., Parrott, S., Coffey, M., Audrey, S., Ure, C., Duffy, P., Ottiwell, D., et al. (2018) · BMC Public Health · doi:10.1186/s12889-018-5410-0 · Cited by 65
“Opportunity cost harms Commissioners may miss opportunities to invest in alternative public health interventions [53] Missed opportunities to identify “at-risk” populations [54] due to stereotyping those ‘in need’ as only the most severe drinking patterns [55] None identified Cook et al.”
BackgroundMartin, S., Lomas, J. R. S., & Claxton, K. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036411 · Cited by 52
Edwards, R. T., & Lawrence, C. L. (2021) · Applied Health Economics and Health Policy · doi:10.1007/s40258-021-00653-5 · Cited by 60
“is being used in public health to quantify the impact of recent disinvestment in public health, during a decade of austerity and coinciding with a move out of the NHS and into local authority in England, UK [39].”
BackgroundTranslating economic evaluations into financing strategies for implementing evidence-based practices
Dopp, A. R., Kerns, S. E. U., Panattoni, L., Ringel, J. S., Eisenberg, D., Powell, B. J., Low, R., & Raghavan, R. (2021) · Implementation Science · doi:10.1186/s13012-021-01137-9 · Cited by 52
Framing the discussion of microorganisms as a facet of social equity in human health
Ishaq, S. L., Rapp, M., Byerly, R., McClellan, L. S., O’Boyle, M. R., Nykanen, A., Fuller, P. J., Aas, C., Stone, J. M., Killpatrick, S., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000536 · Cited by 51
Worthington, J., Feletto, E., Lew, J., Broun, K., Durkin, S. J., Wakefield, M. A., Grogan, P. B., HARPER, T. A., & Canfell, K. (2019) · Public Health · doi:10.1016/j.puhe.2019.10.003 · Cited by 49
Nardini, C., Osmani, V., Cormio, P. G., Frosini, A., Turrini, M., Lionis, C. D., Neumuth, T., Ballensiefen, W., Borgonovi, E., & D’Errico, G. (2021) · Personalized Medicine · doi:10.2217/pme-2020-0115 · Cited by 60
Funding for public health in Europe in decline?
(2018) · doi:10.1016/j.healthpol.2018.11.014 · Cited by 47
“…or commercial lobby groups in favour of public health, the invisibility of the long-term (and short-term) benefits of public health interventions, a failure of the public health community to make a convincing case for continued investment, and powerful opposing commercial interests [30-32].”
BackgroundInfluentialKypridemos, C., Collins, B., McHale, P., Bromley, H., Parvulescu, P., Capewell, S., & O’Flaherty, M. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002573 · Cited by 60
Self-citationSaito, M., Aida, J., Kondo, N., Saito, J., Kato, H., Ota, Y., Amemiya, A., & Kondo, K. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024439 · Cited by 48
Cost-Effectiveness Analysis of The Real Cost Campaign's Effect on Smoking Prevention
MacMonegle, A. J., Nonnemaker, J. M., Duke, J. C., Farrelly, M. C., Zhao, X., Delahanty, J. C., Smith, A. A., Rao, P., & Allen, J. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.05.006 · Cited by 49
Kriegner, S., Ottersen, T., Røttingen, J., & Gopinathan, U. (2020) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2020.19 · Cited by 46
“Semistructured interviews aimed to elicit views and experiences of individuals involved in the evaluation of PHIs.41,42 An interview guide was developed (Supplementary file 1), informed by a literature review of strategies for promoting intersectoral collaboration through the evaluation of PHIs.41,42 When designing th…”
BackgroundInfluentialMeasuring the Built Environment in Studies of Child Health—A Meta-Narrative Review of Associations
Ortegón-Sánchez, A., McEachan, R., Albert, A. E., Cartwright, C., Christie, N., Dhanani, A., Islam, S., Ucci, M., & Vaughan, L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010741 · Cited by 46
“Improving health in childhood thus has the greatest potential for the prevention of later chronic disease [7,9], with the cost savings associated with “preventing” ill health being well established [10].”
BackgroundNayagam, S., Chan, P., Zhao, K., Sicuri, E., Wang, X., Jia, J., Wei, L., Walsh, N. M., Rodewald, L. E., Zhang, G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa134 · Cited by 47
“A review of ROI of public health interventions revealed wide ranges of returns from 1 to 14.3 and methodology was heterogeneous between studies [32].”
BackgroundMethodInfluentialShow me the money: how do we justify spending health care dollars on digital health?
Woods, L. S., Eden, R., Canfell, O. J., Nguyen, K., Comans, T. A., & Sullivan, C. M. (2022) · The Medical Journal of Australia · doi:10.5694/mja2.51799 · Cited by 42
SCHOFIELD, D. J., Cunich, M. M., Shrestha, R. N., Tanton, R., Veerman, L. J., Kelly, S., & Passey, M. E. (2018) · BMC Public Health · doi:10.1186/s12889-018-5509-3 · Cited by 41
“Current lost labour force participation due to arthritis – where ‘arthritis’ refers to a number of different conditions leading to inflamed or damaged joints, with the main conditions for people aged 45-64 years being OA and RA [5] – will impact on the future capacity of patients to maintain an adequate standard of li…”
BackgroundThe social value of investing in public health across the life course: a systematic scoping review
Ashton, K., Schröder‐Bäck, P., Clemens, T., Dyakova, M., Stielke, A., & Bellis, M. A. (2020) · BMC Public Health · doi:10.1186/s12889-020-08685-7 · Cited by 39
“This is underpinned by a broad evidence base illustrating the return on investment in economic terms and value for money of investing in public health interventions across the life course [1, 3, 4].”
BackgroundGebreslassie, M., Sampaio, F., Nystrand, C., Ssegonja, R., & Feldman, I. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106100 · Cited by 45
The QALY at 50: One story many voices
Spencer, A. E., Rivero‐Arias, O., Wong, R., Tsuchiya, A., Bleichrodt, H., Edwards, R. T., Norman, R., Lloyd, A. J., & Clarke, P. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114653 · Cited by 35
Williams, P. J., Buttery, S. C., Laverty, A. A., & Hopkinson, N. S. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202309-1650ci · Cited by 39
“There are other economic arguments that addressing structural violence is a general good: investment in public health is likely to improve economic performance, a general bene fi t that goes beyond just those who are prevented from developing COPD or where the impact of the condition is reduced (97).”
BackgroundThusini, S., Milenova, M., Nahabedian, N., Grey, B., Soukup, T., Chua, K., & Henderson, C. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08832-3 · Cited by 58
Precision health in behaviour change interventions: A scoping review
Mauch, C. E., Edney, S. M., Viaña, J. N. M., Gondalia, S. V., Sellak, H., Boud, S. J., Nixon, D. D., & Ryan, J. C. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2022.107192 · Cited by 41
Turner, H. C., Hori, Y., Revill, P. A., Rattanavipapong, W., Arai, K., Nonvignon, J., Jit, M., & Teerawattananon, Y. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-012798 · Cited by 33
“4 However, this study focused on examining the ROI values that have been estimated for existing public health interventions and the details of the specific methodology of the studies fell outside of the study’s scope.”
A vision for population health: towards a healthier future
Buck, D., Baylis, A., Dougall, D., et al. (2018) · Cited by 32
The politics of public health investments
Jacques, O., & Noël, A. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.115272 · Cited by 41
Fogg, C., England, T., Zhu, S., Jones, J., de Lusignan, S., Fraser, S. D., Roderick, P. J., Clegg, A. P., Harris, S., Brailsford, S., et al. (2024) · Age and Ageing · doi:10.1093/ageing/afae010 · Cited by 32
“Public health prevention strategies are likely to be more cost-effective compared to health service interventions [44] and need to be used in conjunction with direct care to support the long-term sustainability of healthcare systems [45].”
BackgroundCanfell, O. J., Littlewood, R., Burton‐Jones, A., & Sullivan, C. M. (2021) · Australian Health Review · doi:10.1071/ah21063 · Cited by 37
Rethinking the COVID-19 Pandemic: Back to Public Health
Collins, T. E., Akselrod, S., Bloomfield, A., Gamkrelidze, A., Jakab, Z., & Placella, E. (2020) · Annals of Global Health · doi:10.5334/aogh.3084 · Cited by 33
Briggs, A. D. M., Cobiac, L. J., Wolstenholme, J. L., & Scarborough, P. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4237-4 · Cited by 35
“Despite shrinking public health budgets, there is still significant potential to improve population health using prevention strategies that may be cost-effective or cost saving [2, 3, 10, 11].”
BackgroundReturn on Investment and Value Research in Neuropsychology: A Call to Arms†
Glen, T., Hostetter, G., Roebuck‐Spencer, T., Garmoe, W. S., Scott, J. G., Hilsabeck, R. C., Arnett, P. A., & Espe‐Pfeifer, P. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaa010 · Cited by 30
Portnoy, A., Arcand, J., Clark, R. A., Weerasuriya, C. K., Mukandavire, C., Bakker, R., Patouillard, E., Gebreselassie, N. G., Zignol, M., Jit, M., et al. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004252 · Cited by 27
“However, the cost–benefit ratio of novel TB vaccine introduction (calculated by dividing total the global economic gains of vaccine introduction by the cost of vaccine introduction and delivery) was relatively high compared to other public health interventions in studies that have examined economic benefits and costs…”
ResultStandaert, B. A., Sauboin, C., DeAntonio, R., Marijam, A., Gomez, J. A., Varghese, L., & Zhang, S. (2020) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2020.1719588 · Cited by 31
Nobles, J., Christensen, A., Butler, M. J., Radley, D., Pickering, K., Saunders, J., Weir, C., Sahota, P., & Gately, P. (2019) · Health Policy · doi:10.1016/j.healthpol.2019.07.016 · Cited by 24
on behalf of the GREPHEPI Group, Figueiras, A., López-Vázquez, P., González-González, C., Vázquez-Lago, J. M., Piñeiro‐Lamas, M., López‐Durán, A., Sánchez, C., Herdeiro, M. T., & Zapata‐Cachafeiro, M. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-00857-9 · Cited by 24
The economic returns of ending the AIDS epidemic as a public health threat
Lamontagne, E., Over, M., & Stover, J. (2018) · Health Policy · doi:10.1016/j.healthpol.2018.11.007 · Cited by 27
Sahota, P., Christian, M. S., Day, R. E., & Cocks, K. (2019) · Pilot and Feasibility Studies · doi:10.1186/s40814-019-0542-2 · Cited by 26
Investment case for primary health care in low- and middle-income countries: A case study of Kenya
Mwai, D., Hussein, S., Olago, A., Kimani, M., Njuguna, D., Njiraini, R., Wangia, E., Olwanda, E. E., Mwaura, L., & Rotich, W. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283156 · Cited by 29
“This finding is consistent with that of a systematic review which concluded that investing in local public health interventions are cost-saving, and offer substantial ROI [25].”
ResultInfluentialUngvari, Z. I., Tabák, Á. G., Ádány, R., Purebl, G., Kaposvári, C., Fazekas‐Pongor, V., Csípő, T., Szarvas, Z., Horváth, K., Mukli, P., et al. (2023) · GeroScience · doi:10.1007/s11357-023-01018-7 · Cited by 33
“Thus, investing resources and money in disease prevention of age-associated diseases and the promotion of healthy aging can yield substantial returns on investment, as demonstrated by the median return on investment and cost–benefit ratios reported in various studies [32].”
BackgroundHarland, J., Adams, E. A., Boobis, S., Cheetham, M., Wiseman, A., & Ramsay, S. E. (2021) · European Journal of Public Health · doi:10.1093/eurpub/ckab142 · Cited by 25
Stuart, R. M., Khan, O., Abeysuriya, R., Kryvchun, T., Лысак, В. П., Bredikhina, A., Durdykulyieva, N., Mykhailets, V., Kaidashova, E., Doroshenko, O., et al. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05261-y · Cited by 32
The Changing Role of the Genetic Counsellor in the Genomics Era
Kohut, K., Limb, S., & Crawford, G. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-00163-w · Cited by 28
Public health: who, what, and why?
Cabaj, J., Musto, R., & Ghali, W. A. (2019) · Canadian Journal of Public Health · doi:10.17269/s41997-019-00207-2 · Cited by 26
Albarqouni, L., Ringsten, M., Montori, V. M., Jørgensen, K. J., Bulbeck, H., & Johansson, M. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2022-000130 · Cited by 24
Makanjuola, A., Lynch, M., Hartfiel, N., Cuthbert, A., & Edwards, R. T. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20126111 · Cited by 25
“A recent systematic review suggests that local and national preventative public health interventions in the UK are highly cost-saving [12].”
BackgroundNystrand, C., Gebreslassie, M., Ssegonja, R., Feldman, I., & Sampaio, F. (2020) · Health Policy · doi:10.1016/j.healthpol.2020.09.002 · Cited by 24
Zucca, P., Rossmann, M.-C., Osorio, J. E., Karem, K. L., Benedictis, P. D., Haißl, J., Franceschi, P. D., Calligaris, E., Kohlweiß, M., Meddi, G., et al. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.593683 · Cited by 23
Geary, R. S., Thompson, D. A., Garrett, J. K., Mizen, A., Rowney, F. M., Song, J., White, M. P., Lovell, R., Watkins, A. J., Lyons, R. A., et al. (2023) · Public Health Research · doi:10.3310/lqpt9410 · Cited by 47
Hadley, T. D., Agha, A. M., & Ballantyne, C. M. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00915-6 · Cited by 22
Torres, E. M., Fernández, Ó., Carrascal, P., Ruíz-Beato, E., Pérez, E. E., Estrada, R. M., Gómez‐García, T., Jiménez, M., Hidalgo‐Vega, Á., & Merino, M. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-4946-8 · Cited by 25
Dopp, A. R., Gilbert, M., Silovsky, J. F., Ringel, J. S., Schmidt, S. R., Funderburk, B. W., Jorgensen, A. G., Powell, B. J., Luke, D. A., Mandell, D. S., et al. (2022) · Implementation Science Communications · doi:10.1186/s43058-021-00234-6 · Cited by 20
Bailey, J., Gerasopoulos, E., Rueda, D. R., & Benmarhnia, T. (2019) · Journal of Environmental Science and Health Part A · doi:10.1080/10934529.2019.1629211 · Cited by 19
Professional football clubs’ involvement in health promotion in Spain: an audit of current practices
Lozano-Sufrategui, L., Pringle, A., Zwolinsky, S., & Drew, K. J. (2019) · Health Promotion International · doi:10.1093/heapro/daz097 · Cited by 21
Turner, A., Mulla, A., Booth, A., Aldridge, S., Stevens, S., Begum, M., & Malik, A. (2018) · Health Services and Delivery Research · doi:10.3310/hsdr06250 · Cited by 23
Fortune, N., Madden, R., Riley, T., & Short, S. D. (2021) · Health Promotion International · doi:10.1093/heapro/daab011 · Cited by 19
Ng, K., Sainio, P., & Sit, C. H. P. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173156 · Cited by 22
“It is, therefore, not surprising that health promotion programs and legislation are considered to be the best methods for cost-effectiveness and return on investment in combatting physical inactivity [7].”
BackgroundRomaní, F., & Cabezas, C. (2018) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2018.354.3817 · Cited by 18
Return on investment of fracture liaison services: a systematic review and analysis
Xu, L., Zhao, T., Perry, L., Frost, S. A., Tanna, G. L. D., Wang, S., Chen, M., Kolt, G. S., Jan, S., & Si, L. (2024) · Osteoporosis International · doi:10.1007/s00198-024-07027-2 · Cited by 19
“…we found that ROI for FLS interventions was in concordance with that for other secondary prevention or chronic disease management programs, such as interventions for hypertension (ROI 7.5–19.35), falls prevention (ROI 19.6), coronary heart disease (ROI 10), and heart failure (ROI 1.15) [21].”
InfluentialMcCrabb, S., Mooney, K., Elton, B., Grady, A., Yoong, S. L., & Wolfenden, L. (2020) · BMC Public Health · doi:10.1186/s12889-020-09950-5 · Cited by 21
“The benefits of such investments are increasingly being scrutinised [1].”
BackgroundTHE IMPACTS OF THE USDA BROADBAND LOAN AND GRANT PROGRAMS: MOVING TOWARD ESTIMATING A RATE OF RETURN
Kandilov, I. T., & Renkow, M. (2019) · Economic Inquiry · doi:10.1111/ecin.12872 · Cited by 16
Evaluating Public Health Interventions: A Neglected Area in Health Technology Assessment
Stojanovic, J., Wübbeler, M., Geis, S., Reviriego, E., Gutiérrez‐Ibarluzea, I., & Lenoir‐Wijnkoop, I. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00106 · Cited by 19
“One of the plausible explanations is that political incentives are lacking since the benefits of PH interventions usually arrive after the mandate of current politicians and policy makers (43).”
BackgroundHensher, M., & Zywert, K. (2020) · BMJ · doi:10.1136/bmj.m4168 · Cited by 25
Collins, B., Bandosz, P., Guzman-Castillo, M., Pearson‐Stuttard, J., Stoye, G., McCauley, J., Ahmadi‐Abhari, S., Araghi, M., Shipley, M. J., Capewell, S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268766 · Cited by 17
“Such investments would actually be cost-saving [29].”
Self-citationEscalating costs of innovative medicines: perspective and proposals
Vallano, A., & Pontes, C. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1449707 · Cited by 23
“…with rising pharmaceutical costs but demands an initial investment in a comprehensive strategy and resources; thus, the investment is often delayed due to the lack of prioritization of the required investment for implementing innovation caused by short-term objectives and budget constraints (71).”
BackgroundCraig, N. J., & Robinson, M. (2019) · Public Health · doi:10.1016/j.puhe.2019.02.013 · Cited by 16
Zhang, Y., McDarby, G., Seifeldin, R., Mustafa, S., Dalil, S., Schmets, G., Muscat, N. A., Fitzgerald, J., Mataria, A., Báscolo, E., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1107192 · Cited by 21
Okamoto, S., Sakamoto, H., Kamimura, K., Komamura, K., Kobayashi, E., & Liang, J. (2023) · Health Economics Review · doi:10.1186/s13561-023-00442-x · Cited by 28
Jackson, L., Al‐Janabi, H., Roberts, T. E., & Ross, J. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113945 · Cited by 22
Woods, L. S., Eden, R., Green, D., Pearce, A., Donovan, R., McNeil, K., & Sullivan, C. M. (2024) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105528 · Cited by 21
Metadata
- Authors
- Masters, R., Anwar, E., Collins, B., Cookson, R., & Capewell, S.
- Affiliations
- University of Liverpool (GB)
- University of York (GB)
- Corresponding author
- Masters, Rebecca
- Venue
- Journal of Epidemiology and Community Health
- Publisher
- BMJ
- Published
- 2017-03-29
- Volume
- 71
- Issue
- 8
- Pages
- 827-834
- ISSN
- 0141-7681 (ISSN-L)
- 0143-005X
- 1470-2738
- PMC
- PMC5537512
- OpenAlex
- W2600916415
- Cited by
- 480
- References
- 58
- Citations by year
- 2026: 56 · 2025: 55 · 2024: 48 · 2023: 46 · 2022: 41 · 2021: 65 · 2020: 62 · 2019: 48 · 2018: 43 · 2017: 14
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Epidemiology & Community Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute for Health and Care Research (SRF-2013-06-015)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Public Health Policies and Education
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Global Health Care Issues
- Keywords
- return on investment, public health interventions, benefit-cost ratio, austerity, local public health, high-income countries, cost reduction
- MeSH terms
- Health Promotion, Public Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

